Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study.
about
Food fortification for bone health in adulthood: a scoping reviewThe Lichfield bone study: the skeletal response to exercise in healthy young menBone turnover and bone mineral density in HIV-1 infected Chinese taking highly active antiretroviral therapy -a prospective observational study.Bone turnover in elderly men: relationships to change in bone mineral densityEffects of Combination Therapy of Alendronate and Hormonal Therapy on Bone Mineral Density in Postmenopausal Korean Women: Multicenter, Randomized Controlled Clinical Trial.Prevention and treatment of postmenopausal osteoporosis.2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 monthsBiochemical markers for assessment of calcium economy and bone metabolism: application in clinical trials from pharmaceutical agents to nutritional products.Discriminants of prevalent fractures in chronic kidney diseaseAssociation of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition.Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.Effects of OsteoKing on osteoporotic rabbitsEffects of Sigma Anti-bonding Molecule Calcium Carbonate on bone turnover and calcium balance in ovariectomized rats.Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover studyEffect of a combination of genistein, polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study.Towards a diagnostic and therapeutic consensus in male osteoporosisQuantifying the Balance Between Total Bone Formation and Total Bone Resorption: An Index of Net Bone Formation.Considerations for development of surrogate endpoints for antifracture efficacy of new treatments in osteoporosis: a perspective.Biomarkers of bone health and osteoporosis risk.Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club.Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS study.Age-related bone turnover markers and osteoporotic risk in native Chinese womenModels and screening assays for drug discovery in osteoporosis.Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: a consensus advice from an Austrian working group.Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study.The Utility of Biomarkers in Osteoporosis Management.Association of bone turnover markers with volumetric bone loss, periosteal apposition, and fracture risk in older men and women: the AGES-Reykjavik longitudinal studyBiochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort.Urinary N-telopeptide and Rate of Bone Loss Over the Menopause Transition and Early Postmenopause.The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.Osteosarcopenia is more than sarcopenia and osteopenia alone.Enhanced bone metabolism in vegetarians--the role of vitamin B12 deficiency.Bone resorption in anorexia nervosa and rehabilitated patients.Potential excessive suppression of bone turnover with long-term oral bisphosphonate therapy in postmenopausal osteoporotic patients.Serum Levels of a Cathepsin-K Generated Periostin Fragment Predict Incident Low-Trauma Fractures in Postmenopausal Women Independently of BMD and FRAX.The potential value of monitoring bone turnover markers among women on alendronate.Primary osteoporosis in postmenopausal women.The challenges of diagnosing osteoporosis and the limitations of currently available tools.Tartrate-resistant acid phosphatase as a biomarker of bone turnover in dog
P2860
Q28072047-D2996C97-758A-4659-ADD4-B133C36591B9Q30458203-8414D5F3-CB39-451C-880D-1EE7C8F52251Q31124706-23F36585-2F93-48AA-AA03-5EEECC2F89A0Q33275032-58FC9110-E6C8-4A3F-8CC4-5D7904F9C8F3Q33661422-621205AC-92C2-4615-BC31-285CFDAA71AEQ34296614-8431F618-BB14-4CF9-B83E-8354FCE4BEC6Q34300668-F89B8F4D-6D01-4AFF-9023-ABBEE5328BE6Q34346418-BC5453BE-D06C-44D3-8522-D4B13CFC80ECQ35017714-8EE84211-FD79-4477-9870-AF6CC2F825F7Q35142758-8290803F-9EF9-4E02-B6E8-9C687A4D9884Q35229974-DEF6EB4F-DC64-4490-ABF9-732DAE35AB58Q35550507-A9C8F720-C1ED-4776-B2D8-5FC920F842F1Q35628178-74976EE3-5B78-428F-899F-841C407C9903Q35653393-6C1CAFBF-86F1-4890-BFE4-7EB7A01C08C8Q36079448-90561122-7B53-405C-B0B5-4E23506668B3Q36546641-E3DEF03C-EC01-4F29-B2A3-DC6340E822A1Q36564415-1E12429C-9D2A-4BE0-9BAC-43AD7D1B618EQ37057960-264C921B-4898-4A95-B585-51F0683BE346Q37101600-06AC27E7-F295-4179-95E3-3C3C675BEF12Q37138648-BC61E6EF-842A-46A2-8E61-A610F0CEEDDAQ37250572-5B03060B-4723-423F-89D9-9D806326D5F8Q37469385-ABEB9A08-85A4-46BF-849A-595756B7D279Q37681874-D9466BF7-9FD1-4FB1-A7BE-98356D4DC7B5Q38028513-14D4E1E7-9523-4A03-B8AB-54556E31C456Q38034435-05EBF24A-B002-475C-BB24-E299EE007986Q38475844-79DB8663-73A9-4D37-B4F8-ED22E20011BCQ38921875-52A24076-60DD-4320-958D-B8C79DEFB2C5Q39656951-86880C99-DFD3-46E9-A1AB-B15F2127E435Q39758026-4CCB8317-1106-45B3-A2F0-20ABBF9B3F78Q40528709-8B6EFC00-DE73-42F2-B178-420B23AFB242Q40828040-A1FA1AF2-21CF-42AC-8451-7DF48CA67FF2Q41127847-73C0FDC2-ABC8-4970-A654-B94C1383B385Q43264515-DBAFF1C1-D3FA-472D-A1C5-DB237DB87386Q44305212-ECC78EB3-225A-40CA-96AC-5C78EEBDDD07Q46470161-1274BC41-13DB-433F-8F61-8EC81E6F4D97Q48000943-F9C30B67-5F72-42F1-ABCF-7D6E4AA16669Q51170565-ADE10B2B-6538-414B-9C6E-EDF8575B9CF8Q55012766-45E9CFE2-BD50-47D6-A191-80CEA90A1875Q55113719-B18FC4EA-D998-4AF8-B473-ACA2429A0787Q57170559-77F6188D-BACB-4385-8DAA-488E793F8132
P2860
Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Markers of bone turnover predi ...... over 4 years: the OFELY study.
@ast
Markers of bone turnover predi ...... over 4 years: the OFELY study.
@en
type
label
Markers of bone turnover predi ...... over 4 years: the OFELY study.
@ast
Markers of bone turnover predi ...... over 4 years: the OFELY study.
@en
prefLabel
Markers of bone turnover predi ...... over 4 years: the OFELY study.
@ast
Markers of bone turnover predi ...... over 4 years: the OFELY study.
@en
P2093
P2860
P1476
Markers of bone turnover predi ...... over 4 years: the OFELY study.
@en
P2093
Sornay-Rendu E
P2860
P304
P356
10.1359/JBMR.1999.14.9.1614
P577
1999-09-01T00:00:00Z